188 related articles for article (PubMed ID: 33913371)
41. Incidental Pathogenic Fibrin-Associated Diffuse Large B-cell Lymphoma Found During Aorto-Biiliac Bypass.
Habib PM; Serena T; Flynn CM; Hartkop A; Wey E; Lang D; Laveroni E
Cureus; 2022 Mar; 14(3):e23681. PubMed ID: 35510016
[TBL] [Abstract][Full Text] [Related]
42. EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
Hong JY; Yoon DH; Suh C; Huh J; Do IG; Sohn I; Jo J; Jung SH; Hong ME; Yoon H; Ko YH; Kim SJ; Kim WS
Ann Oncol; 2015 Mar; 26(3):548-55. PubMed ID: 25475080
[TBL] [Abstract][Full Text] [Related]
43. EBV-negative Fibrin-Associated Large B-Cell Lymphoma Arising in Thyroid Hyperplastic Nodule: Report of a Case and Literature Review.
Ho TW; Cheuk W; Chan JKC
Int J Surg Pathol; 2023 Oct; 31(7):1420-1425. PubMed ID: 36843554
[TBL] [Abstract][Full Text] [Related]
44. Microscopic diffuse large B-cell lymphoma (DLBCL) occurring in pseudocysts: do these tumors belong to the category of DLBCL associated with chronic inflammation?
Boroumand N; Ly TL; Sonstein J; Medeiros LJ
Am J Surg Pathol; 2012 Jul; 36(7):1074-80. PubMed ID: 22472958
[TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS
J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026
[TBL] [Abstract][Full Text] [Related]
46. Diffuse large B-cell lymphoma.
Li S; Young KH; Medeiros LJ
Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
[TBL] [Abstract][Full Text] [Related]
47. Cytological Features of Fibrin-associated Diffuse Large B-cell Lymphoma Arising in Retroperitoneal Pseudocyst: The First Case Report.
Na K; Kim SW; Kim HS
In Vivo; 2024; 38(3):1477-1482. PubMed ID: 38688594
[TBL] [Abstract][Full Text] [Related]
48. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
49. Primary cardiac lymphoma mimicking left atrial myxoma in an immunocompetent patient.
Nguyen DT; Meier CR; Schneider D
J Clin Oncol; 2008 Jan; 26(1):150-2. PubMed ID: 18165648
[No Abstract] [Full Text] [Related]
50. The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.
Keane C; Tobin J; Gunawardana J; Francis S; Gifford G; Gabrielli S; Gill A; Stevenson W; Talaulikar D; Gould C; Jain S; Birch S; Hertzberg M; Gandhi MK
Eur J Haematol; 2019 Sep; 103(3):200-207. PubMed ID: 31211907
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus-associated diffuse large B-cell lymphoma arising on cardiac prostheses.
Miller DV; Firchau DJ; McClure RF; Kurtin PJ; Feldman AL
Am J Surg Pathol; 2010 Mar; 34(3):377-84. PubMed ID: 20139760
[TBL] [Abstract][Full Text] [Related]
52. Development of EBV-encoded small RNA targeted PCR to classify EBV positive diffuse large B-cell lymphoma (DLBCL) of the elderly.
Lee J; Park M; Lee MH; Woo HJ; Kim HW; Yang JY; Eom YB; Kim SH; Yoo C; Kim JB
Int J Clin Exp Pathol; 2015; 8(7):7859-68. PubMed ID: 26339350
[TBL] [Abstract][Full Text] [Related]
53. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.
Castillo JJ; Beltran BE; Miranda RN; Young KH; Chavez JC; Sotomayor EM
Am J Hematol; 2016 May; 91(5):529-37. PubMed ID: 27093913
[TBL] [Abstract][Full Text] [Related]
54. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Beltran BE; Quiñones P; Morales D; Malaga JM; Chavez JC; Sotomayor EM; Castillo JJ
Hematol Oncol; 2018 Feb; 36(1):93-97. PubMed ID: 28639256
[TBL] [Abstract][Full Text] [Related]
55. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
[TBL] [Abstract][Full Text] [Related]
56. Epstein Barr Virus Infection Can be a Secondary Event in B-Cell Lymphomas: A Review of 338 Cases and a Novel Finding of Zonal EBER+ Tumor Cells Showing Features of Progression From Underlying EBV-negative Lymphoma.
Miller IJ
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):165-173. PubMed ID: 28800008
[TBL] [Abstract][Full Text] [Related]
57. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management.
Castillo JJ; Beltran BE; Miranda RN; Young KH; Chavez JC; Sotomayor EM
Am J Hematol; 2018 Jul; 93(7):953-962. PubMed ID: 29984868
[TBL] [Abstract][Full Text] [Related]
58. Diffuse large B-cell lymphoma occurring in an ovarian cystic teratoma: expanding the spectrum of large B-cell lymphoma associated with chronic inflammation.
Valli R; Froio E; Alvarez de Celis MI; Mandato VD; Piana S
Hum Pathol; 2014 Dec; 45(12):2507-11. PubMed ID: 25439346
[TBL] [Abstract][Full Text] [Related]
59. A distinctive subgroup of oral EBV+ B-cell neoplasm with polymorphous features is potentially identical to EBV+ mucocutaneous ulcer.
Ohata Y; Tatsuzawa A; Ohyama Y; Ichikawa A; Mochizuki Y; Ishibashi S; Itakura Y; Sakurai U; Sakamoto K; Ikeda T; Kitagawa M; Yamamoto K
Hum Pathol; 2017 Nov; 69():129-139. PubMed ID: 28993276
[TBL] [Abstract][Full Text] [Related]
60. Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren's syndrome.
Gorodetskiy VR; Probatova NA; Vasilyev VI
Int J Rheum Dis; 2020 Apr; 23(4):540-548. PubMed ID: 32100426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
